Silo Pharma, Inc. announced a service agreement with Resyca BV to conduct a drug-device study on its microchip-based nasal spray system for SPC-15, an intranasal treatment for PTSD. This study aims to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback